LogicBio Therapeutics
Develops gene therapy vectors for previously incurable genetic and infectious diseases including hemophilia, HIV/AIDS, and methylmalonic acidemia. Learn more
Launch date
Employees
Market cap
€127m
Enterprise valuation
(€10m) (Public information from Sep 2024)
Share price
$5.4 LOGC
Cambridge Massachusetts (HQ), Ness Ziona Center District (founding location)
Authorizing premium user...